PUNE, India, July 12, 2016 /PRNewswire/ --
Global and highly mature type 2 diabetics market is forecast to be worth$58.7 Billion by 2025 with epidemiologists forecasting an increase in the diagnosed prevalent cases of T2D in the 9MM, from 116,871,808 diagnosed prevalent cases in 2015 to 151,907,657 diagnosed prevalent cases in 2025,
Complete report on Type 2 Diabetes Epidemiology Forecast to 2025 of 69 pages with 10 tables and 7 figures is now available at http://www.rnrmarketresearch.com/epicast-report-type-2-diabetes-epidemiology-forecast-to-2025-market-report.html .
RnRMarketResearch.com adds "EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2025" to its store providing an overview of the risk factors and global trends of type 2 diabetics market in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, China, and India). It includes a 10-year epidemiology forecast of T2D diagnosed prevalent cases segmented by age (in ten-year increments beginning at ages 20-30 years and ending at age 80 years and older), sex, and comorbidities including chronic kidney disease (CKD), cardiovascular disease (CVD), overweight/obesity, hypertension, and dyslipidemia in these nine markets. The projected increase in the diagnosed prevalent cases of type 2 diabetics market across all major regions covered in this analysis is attributed to the actual increase in the incidence of T2D along with the change in population demographics in the respective markets.
This epidemiologists utilized country-specific diagnosed prevalence data for type 2 diabetics market across the 9MM. Additionally, the epidemiological forecast for the diagnosed prevalent cases of T2D in the 9MM is supported by nationally representative longitudinal historical data obtained from studies in respective countries published in peer-reviewed journals or national healthcare databases, which provide a detailed insight into the epidemiology of the disease in these type 2 diabetics markets.
Order a copy of type 2 diabetics market epidemiology forecast to 2025 research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=629933 .
Type 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the body's inability to make use of available insulin along with relative insulin deficiency. T2D constitutes approximately 90% of all diabetes cases around the world; type 1 diabetes (T1D) and gestational diabetes make up the remaining 10% of the cases. Risk factors for type 2 diabetics market are broadly categorized as either modifiable or non-modifiable risk factors. Lifestyle factors such as obesity, physical inactivity, and dietary habits are modifiable risk factors, whereas family history and advancing age are non-modifiable risk factors. T2D is also associated with several comorbidities, such as CKD, CVD, hypertension, and dyslipidemia, which can worsen the quality of life of the patient, and can lead to poor therapeutic outcomes. Diabetes is one of the most common non-communicable diseases worldwide and is an escalating public health problem globally.
Another newly published market research titled EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2025 to its database. The research provides an overview of the risk factors, comorbidities, and global trends for IPF in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast of the diagnosed incident and diagnosed prevalent cases of IPF segmented by sex, age (in five-year increments beginning at 18 years and ending at =85 years), and severity in these markets. Epidemiologists forecast that the diagnosed incident cases of IPF will increase from 53,139 cases in 2015 to 62,258 cases in 2025, at an Annual Growth Rate (AGR) of 1.72%. The US will have the highest number of diagnosed incident cases of IPF among the 7MM throughout the forecast period, while Spain will have the lowest. The diagnosed prevalent cases of IPF will also increase from 118,943 cases in 2015 to 137,984 cases in 2025, at an AGR of 1.60%. Complete report on Idiopathic Pulmonary Fibrosis market research report of 55 pages is available at http://www.rnrmarketresearch.com/epicast-report-idiopathic-pulmonary-fibrosis-epidemiology-forecast-to-2025-market-report.html .
Explore more reports on Diseases & treatment market at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment .
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect with Us:
G+/Google Plus: https://plus.google.com/104156468549256253075/posts
Contact: Ritesh Tiwari UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune - 411013 Maharashtra, India. Tel: +1-888-391-5441 [email protected]
SOURCE RnR Market Research
Subscribe to our Free Newsletters!
Erythropoietin is a hormone secreted by kidneys in response to low oxygen levels in tissues ...
Local anesthesia is a type of anesthesia generally used to block pain sensation only in a specific ...
Sea food allergy is the adverse response of the body''s immune system to the proteins present in ...View All